Israa Ali Abdul Kareem Al-Samarai (1), Hanan N. Mohammed (2)
General Background: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder among women of reproductive age, characterized by hormonal and metabolic imbalances that impair fertility and overall health. Specific Background: Recent studies have emphasized the crucial role of oxidative stress in PCOS pathogenesis, where excessive reactive oxygen species (ROS) and reduced antioxidant capacity lead to cellular and molecular damage. Knowledge Gap: Despite extensive research on PCOS, the mechanistic link between oxidative imbalance and PCOS progression, particularly the interplay between endogenous and exogenous antioxidants, remains insufficiently understood. Aims: This review aims to elucidate the relationship between oxidative stress and antioxidant systems in PCOS and to identify potential therapeutic roles of antioxidants in mitigating PCOS symptoms. Results: The synthesis of current findings demonstrates that antioxidant deficiency correlates with increased insulin resistance, ovulatory dysfunction, and chronic inflammation in PCOS patients. Supplementation with vitamins C and E, selenium, and metformin enhances oxidative balance, improves ovarian function, and reduces metabolic risks. Novelty: This study integrates biochemical, metabolic, and therapeutic perspectives on antioxidant-mediated modulation of PCOS. Implications: Strengthening antioxidant defenses presents a promising adjunctive strategy to traditional PCOS management, potentially improving reproductive outcomes and reducing long-term comorbidities
Highlights:
Oxidative imbalance contributes significantly to PCOS pathogenesis.
Antioxidant therapy improves hormonal and metabolic regulation.
Combining antioxidants with lifestyle changes enhances treatment outcomes.
Keywords: Polycystic Ovary Syndrome, Oxidative Stress, Antioxidants, Insulin Resistance, Reproductive Health
[1] G. Pizzino, N. Irrera, M. Cucinotta, et al., “Oxidative Stress: Harms and Benefits for Human Health,” Oxidative Medicine and Cellular Longevity, 2017, Art. no. 8416763.
[2] M. Valko, D. Leibfritz, J. Moncol, et al., “Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease,” International Journal of Biochemistry & Cell Biology, vol. 39, no. 1, pp. 44–84, 2007.
[3] C. E. Ofoedu, L. You, and C. M. Osuji, “Hydrogen Peroxide Effects on Naturally-Sourced Polysaccharides: Free Radical Formation/Production, Degradation Process, and Reaction Mechanism—A Critical Synopsis,” Foods, vol. 10, no. 4, p. 699, 2021.
[4] H. Sies, V. V. Belousov, and N. S. Chandel, “Defining Roles of Specific Reactive Oxygen Species (ROS) in Cell Biology and Physiology,” Nature Reviews Molecular Cell Biology, vol. 23, no. 7, pp. 499–515, 2022.
[5] S. Anand and N. Bharadvaja, “Potential Benefits of Nutraceuticals for Oxidative Stress Management,” Revista Brasileira de Farmacognosia, vol. 32, no. 2, pp. 211–220, 2022.
[6] L. E. de Groot, T. A. van der Veen, and F. O. Martinez, “Oxidative Stress and Macrophages: Driving Forces Behind Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease?,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 316, no. 2, pp. L369–L384, 2021.
[7] H. J. Forman and H. Zhang, “Targeting Oxidative Stress in Disease: Promise and Limitations of Antioxidant Therapy,” Nature Reviews Drug Discovery, vol. 20, no. 9, pp. 689–709, 2021.
[8] A. T. Alahmar, “Role of Oxidative Stress in Male Infertility: An Updated Review,” Journal of Human Reproductive Sciences, vol. 12, no. 1, pp. 4–18, 2019.
[9] S. Di Meo and P. Venditti, “Evolution of the Knowledge of Free Radicals and Other Oxidants,” Oxidative Medicine and Cellular Longevity, vol. 2020, Art. no. 9829176.
[10] I. Marrocco, F. Altieri, and I. Peluso, “Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans,” Oxidative Medicine and Cellular Longevity, vol. 2017, Art. no. 8416763.
[11] R. J. Bloomer and A. H. Goldfarb, “Anaerobic Exercise and Oxidative Stress: A Review,” Canadian Journal of Applied Physiology, vol. 29, pp. 245–263, 2004.
[12] V. Ngo and M. L. Duennwald, “Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease,” Antioxidants, vol. 11, no. 12, p. 2345, 2022.
[13] N. Gadoth and H. Göbel, Oxidative Stress and Free Radical Damage in Neurology, in Oxidative Stress in Applied Basic Research and Clinical Practice, Totowa, NJ: Humana Press, 2011, p. 323.
[14] J. L. Martindale and N. J. Holbrook, “Cellular Response to Oxidative Stress: Signaling for Suicide and Survival,” Journal of Cellular Physiology, vol. 192, no. 1, pp. 1–15, 2002.
[15] R. Kohen and A. Nyska, “Oxidation of Biological Systems: Oxidative Stress and Antioxidants,” Toxicologic Pathology, vol. 30, pp. 620–630, 2002.
[16] B. E. Domènech and G. Marfany, “The Relevance of Oxidative Stress in the Pathogenesis and Therapy of Retinal Dystrophies,” Antioxidants, vol. 9, no. 4, p. 347, 2020.
[17] E. Fleming and Y. Luo, “Co-Delivery of Synergistic Antioxidants from Food Sources for the Prevention of Oxidative Stress,” Journal of Agriculture and Food Research, vol. 3, p. 100107, 2021.
[18] F. Xiao, T. Xu, and B. Lu, “Guidelines for Antioxidants Assays for Food Components,” Food Frontiers, vol. 1, no. 1, pp. 60–69, 2020.
[19] M. Parcheta, R. Świsłocka, and S. Orzechowska, “Recent Developments in Ineffective Antioxidants: The Structure and Antioxidant Properties,” Materials, vol. 14, no. 8, p. 1984, 2021.
[20] İ. Gülçin, “Antioxidants and Antioxidant Methods: An Updated Overview,” Archives of Toxicology, vol. 94, no. 3, pp. 651–715, 2020.
[21] A. Marino, M. Battaglini, and N. Moles, “Natural Antioxidant Compounds as Potential Pharmaceutical Tools Against Neurodegenerative Diseases,” ACS Omega, vol. 7, no. 30, pp. 25974–25990, 2022.
[22] A. M. Pisoschi, A. Pop, and F. Iordache, “Antioxidant Determination with the Use of Carbon-Based Electrodes,” Chemosensors, vol. 9, no. 4, p. 72, 2021.
[23] L. P. Calegari, J. Barbosa, and G. A. Marodin, “A Conjoint Analysis to Consumer Choice in Brazil: Defining Device Attributes for Recognizing Customized Foods Characteristics,” Food Research International, vol. 109, pp. 1–13, 2018.
[24] A. M. Pisoschi, A. Pop, and F. Iordache, “Oxidative Stress Mitigation by Antioxidants—An Overview on Their Chemistry and Influences on Health Status,” European Journal of Medicinal Chemistry, vol. 209, p. 112891, 2021.
[25] F. Inchingolo, A. M. Inchingolo, and G. Latini, “Oxidative Stress and Natural Products in Orthodontic Treatment: A Systematic Review,” Nutrients, vol. 16, no. 1, p. 113, 2023.
[26] Z. Liu, M. Wang, and C. Zhang, “Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, pp. 695–711, 2022.
[27] K. Bigot, P. Gondouin, and R. Bénard, “Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration,” Pharmaceutics, vol. 12, no. 9, p. 836, 2020.
[28] J. P. Merlin, H. P. Rupasinghe, and G. Dellaire, “Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression,” Oxidative Medicine and Cellular Longevity, vol. 2021, Art. no. 9924328.
[29] M. Liu, X. Sun, and B. Chen, “Insights into Manganese Superoxide Dismutase and Human Diseases,” International Journal of Molecular Sciences, vol. 23, no. 24, p. 15893, 2022.
[30] P. Nguyen-Powanda and B. Robaire, “Aging and Oxidative Stress Alter DNA Repair Mechanisms in Male Germ Cells of Superoxide Dismutase-1-Null Mice,” Biology of Reproduction, vol. 105, no. 4, pp. 944–957, 2021.
[31] P. Sykora, S. Kanno, and M. Akbari, “DNA Polymerase Beta Participates in Mitochondrial DNA Repair,” Molecular and Cellular Biology, vol. 37, no. 16, e00237, 2017.
[32] C. Gu, Q. Zhou, and X. Hu, “Melatonin Rescues the Mitochondrial Function of Bone Marrow-Derived Mesenchymal Stem Cells and Improves the Repair of Osteoporotic Bone Defect in Ovariectomized Rats,” Journal of Pineal Research, vol. 76, no. 1, e12924, 2024.
[33] J. Bouayed and T. Bohn, “Exogenous Antioxidants—Double-Edged Swords in Cellular Redox State: Health Beneficial Effects at Physiologic Doses Versus Deleterious Effects at High Doses,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 4, pp. 228–237, 2010.
[34] O. O. Sinbad, A. A. Folorunsho, and O. L. Olabisi, “Vitamins as Antioxidants,” Journal of Food Science and Nutrition Research, vol. 2, no. 3, pp. 214–235, 2019.
[35] A. R. Silva, T. C. Finimundy, and L. Barros, “Antioxidant Methodology: Approaches to Activity Determination,” in Handbook of Antioxidant Methodology, P. D. Prenzler, D. Ryan, and K. Robards, Eds., Cambridge, UK: Royal Society of Chemistry, 2021, pp. 203–245.
[36] R. R. Kotha, F. S. Tareq, and E. Yildiz, “Oxidative Stress and Antioxidants—A Critical Review on In Vitro Antioxidant Assays,” Antioxidants, vol. 11, no. 12, p. 2388, 2022.
[37] Z. Wang, M. Liang, and H. Li, “Methionine Activates Nrf2-ARE Pathway to Induce Endogenous Antioxidant Activity for Depressing ROS-Derived Oxidative Stress in Growing Rats,” Journal of the Science of Food and Agriculture, vol. 99, no. 10, pp. 4849–4862, 2019.
[38] B. J. Mathis, H. Kato, and Y. Matsuishi, “Endogenous and Exogenous Protection from Surgically Induced Reactive Oxygen and Nitrogen Species,” Surgery Today, vol. 54, no. 1, pp. 1–13, 2024.
[39] L. Han, Q. Yang, and W. Ma, “Protocatechuic Acid Ameliorated Palmitic-Acid-Induced Oxidative Damage in Endothelial Cells through Activating Endogenous Antioxidant Enzymes via an AMPK-Dependent Pathway,” Journal of Agricultural and Food Chemistry, vol. 66, no. 40, pp. 10400–10409, 2018.
[40] I. Mironczuk-Chodakowska, A. M. Witkowska, and M. E. Zujko, “Endogenous Non-Enzymatic Antioxidants in the Human Body,” Advances in Medical Sciences, vol. 63, no. 1, pp. 68–78, 2018.
[41] Z. Moussa, Z. M. Judeh, and S. A. Ahmed, “Nonenzymatic Exogenous and Endogenous Antioxidants,” Free Radical Medicine and Biology, vol. 1, pp. 11–22, 2019.
[42] B. P. Kuti and O. A. Oyelami, “Serum Nonenzymatic Antioxidants in Nigerian Children with Severe Pneumonia: Association with Complications and Hospital Outcomes,” Pediatric Respirology and Critical Care Medicine, vol. 4, no. 1, p. 2, 2020.
[43] A. Varesi, L. I. M. Campagnoli, and A. Carrara, “Non-Enzymatic Antioxidants Against Alzheimer’s Disease: Prevention, Diagnosis and Therapy,” Antioxidants, vol. 12, no. 1, p. 180, 2023.
[44] C. E. Pirotta, A. Mousa, and L. Moran, “Providing Lifestyle Advice to Women with PCOS: An Overview of Practical Issues Affecting Success,” Nutrients, 2021, pp. 1–12.
[45] G. Creatsas and E. Deligeoroglou, “Polycystic Ovarian Syndrome in Adolescents,” Current Opinion in Obstetrics and Gynecology, vol. 19, no. 5, pp. 420–426, 2023.
[46] M. Jaripur, H. Ghasemi-Tehrani, and G. Askari, “The Effects of Magnesium Supplementation on Abnormal Uterine Bleeding, Alopecia, Quality of Life, and Acne in Women with Polycystic Ovary Syndrome: A Randomized Clinical Trial,” Reproductive Biology and Endocrinology, vol. 20, no. 1, pp. 1–11, 2022.
[47] I. Kowalska, “Changes in Metabolic Profile in the Women with a History of PCOS — A Long-Term Follow-Up Study,” Journal of Clinical Medicine, 2020.
[48] A. Wawrzkiewicz-Jałowiecka, “In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond,” International Journal of Molecular Sciences, vol. 21, no. 19, pp. 1–24, 2020.
[49] K. Nahar, “Polycystic Ovary Syndrome in Teenage and Young Women,” Journal of Bangladesh College of Physicians and Surgeons, vol. 37, no. 2, pp. 78–82, 2019.
[50] S. Panchal and C. B. Nagori, “Sonographic Panorama of PCOS to Explain Its Endocrinal Orchestra,” International Journal of Human Reproduction Research and Development, vol. 1, no. 1, pp. 27–38, 2021.
[51] G. Bozdag, S. Mumusoglu, and D. Zengin, “The Prevalence and Phenotypic Features of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis,” Human Reproduction, vol. 31, no. 12, pp. 2841–2855, 2016.
[52] L. S. S., H. S. K., V. R. E., N. R. J., T. H. J., and M. L. J., “Lifestyle Changes in Women with Polycystic Ovary Syndrome (Review),” Biomedical Reports, 2019.
[53] J. Bulsara, P. Patel, A. Soni, and S. Acharya, “A Review: Brief Insight into Polycystic Ovarian Syndrome,” Endocrine and Metabolic Science, vol. 3, no. 2, p. 100085, 2021.
[54] N. Alhalabi, M. M. Alhalabi, S. Alsamawi, and M. Alhalabi, “Ovulation Stigma and Rupture of Ovarian Tunica Albuginea in a Patient with Polycystic Ovary Syndrome (Video),” Journal of Surgical Case Reports, vol. 2021, no. 10, rjab482, 2021.
[55] A. Guscott, A. Deslandes, and N. Parange, “Australasian Sonographers’ Knowledge, Awareness, and Attitudes Towards the International Evidence-Based Guidelines for the Diagnosis of Polycystic Ovarian Syndrome,” Australasian Journal of Ultrasound in Medicine, vol. 26, no. 2, 2023.
[56] A. T. Brinca, “Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome,” Biomedicines, vol. 10, no. 6, pp. 1–27, 2022.
[57] A. K. M. Salman Hosain, M. H. K. Mehedi, and I. E. Kabir, “PCONet: A Convolutional Neural Network Architecture to Detect Polycystic Ovary Syndrome (PCOS) from Ovarian Ultrasound Images,” in Proc. 8th Int. Conf. Engineering and Emerging Technology (ICEET), pp. 27–28, 2022.
[58] E. Khashchenko, “The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents,” Journal of Clinical Medicine, vol. 9, no. 6, pp. 1–12, 2020.
[59] J. Parker, “Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment,” International Journal of Environmental Research and Public Health, vol. 19, no. 3, p. 1336, 2022.
[60] A. S. Chouhan, “Advance Research on Polycystic Ovary Syndrome (PCOS),” Journal of Women’s Healthcare and Midwifery Research, vol. 1, no. 2, pp. 1–5, 2022.
[61] T. Girase, “Clomiphene Citrate as Nanomedicine Assistance in Ovulatory Disorders and Its Hyphenated Techniques,” Materials Proceedings, vol. 14, 2023.
[62] N. K. Kuscu and A. Var, “Oxidative Stress but Not Endothelial Dysfunction Exists in Non-Obese, Young Group of Patients with Polycystic Ovary Syndrome,” Acta Obstetricia et Gynecologica Scandinavica, vol. 88, no. 5, pp. 612–617, 2009.
[63] S. B. Al-Takriti, “The Role of Hepcidin Hormone and Some Biochemical Variables in the Sera of Patients with Polycystic Ovary Syndrome in Kirkuk,” Ph.D. dissertation, College of Science, Tikrit Univ., Iraq, 2017.
[64] M. Ciebiera and E. E. Hennig, “Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside,” International Journal of Molecular Sciences, vol. 24, no. 18, p. 14126, 2023.
[65] R. Asally, R. Markham, and F. Manconi, “Mitochondrial DNA Haplogroup H Association with Endometriosis and Possible Role in Inflammation and Pain,” Journal of Endometriosis and Pelvic Pain Disorders, vol. 12, pp. 158–164, 2020.
[66] P. Kowalczyk, D. Sulejczak, and P. Kleczkowska, “Mitochondrial Oxidative Stress—A Causative Factor and Therapeutic Target in Many Diseases,” International Journal of Molecular Sciences, vol. 22, p. 13384, 2021.
[67] G. Hudson, P. Amati-Bonneau, and E. L. Blakely, “Mutation of OPA1 Causes Dominant Optic Atrophy with External Ophthalmoplegia, Ataxia, Deafness and Multiple Mitochondrial DNA Deletions: A Novel Disorder of MtDNA Maintenance,” Brain, vol. 131, pp. 329–337, 2008.
[68] N. Zeber-Lubecka, M. Ciebiera, and E. E. Hennig, “Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside,” International Journal of Molecular Sciences, vol. 24, no. 18, p. 14126, 2023.
[69] A. Stejskalova, “In Vitro Modelling of the Physiological and Diseased Female Reproductive System,” Acta Biomaterialia, pp. 1–59, 2021.
[70] T. Sabuncu, H. Vural, and M. Harma, “Oxidative Stress in Polycystic Ovary Syndrome and Its Contribution to the Risk of Cardiovascular Disease,” Clinical Biochemistry, vol. 34, pp. 407–413, 2001.
[71] S. Mahalingaiah and E. Diamanti-Kandarakis, “Targets to Treat Metabolic Syndrome in Polycystic Ovary Syndrome,” Expert Opinion on Therapeutic Targets, vol. 19, pp. 1561–1574, 2015.
[72] P. C. Piotrowski, I. J. Rzepczynska, and J. Kwintkiewicz, “Oxidative Stress Induces Expression of CYP11A, CYP17, Star and 3β-HSD in Rat Theca-Interstitial Cells,” Journal of the Society for Gynecologic Investigation, vol. 12, p. 319A, 2005.
[73] A. M. Kicinska, R. B. Maksym, and M. A. Zabielska-Kaczorowska, “Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome,” Biomedicines, vol. 11, p. 1567, 2023.
[74] F. Yan, Q. Zhao, and Y. Li, “The Role of Oxidative Stress in Ovarian Aging: A Review,” Journal of Ovarian Research, vol. 15, p. 100, 2022.
[75] A. M. Darling, J. E. Chavarro, and S. Malspeis, “A Prospective Cohort Study of Vitamins B, C, E, and Multivitamin Intake and Endometriosis,” Journal of Endometriosis and Pelvic Pain Disorders, vol. 5, pp. 17–26, 2013.
[76] H. Heidari, Z. Hajhashemy, and P. Saneei, “A Meta-Analysis of Effects of Vitamin E Supplementation Alone and in Combination with Omega-3 or Magnesium on Polycystic Ovary Syndrome,” Scientific Reports, vol. 12, p. 19927, 2022.
[77] O. T. Olaniyan, A. Femi, and G. Iliya, “Vitamin C Suppresses Ovarian Pathophysiology in Experimental Polycystic Ovarian Syndrome,” Pathophysiology, vol. 26, pp. 331–341, 2019.
[78] P. V. Dludla, B. B. Nkambule, and T. M. Nyambuya, “Vitamin C Intake Potentially Lowers Total Cholesterol to Improve Endothelial Function in Diabetic Patients at Increased Risk of Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials,” Frontiers in Nutrition, vol. 9, p. 1011002, 2022.
[79] M. P. McRae, “Vitamin C Supplementation Lowers Serum Low-Density Lipoprotein Cholesterol and Triglycerides: A Meta-Analysis of 13 Randomized Controlled Trials,” Journal of Chiropractic Medicine, vol. 7, pp. 48–58, 2008.
[80] B. Bai and H. Chen, “Metformin: A Novel Weapon Against Inflammation,” Frontiers in Pharmacology, vol. 12, p. 622262, 2021.
[81] T. Salvatore, P. C. Pafundi, and R. Galiero, “Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?,” Biomedicines, vol. 9, no. 3, p. 210, 2020.
[82] S. Sam and D. A. Ehrmann, “Metformin Therapy for the Reproductive and Metabolic Consequences of Polycystic Ovary Syndrome,” Diabetologia, vol. 60, pp. 1656–1662, 2017.
[83] J. Zhao, L. Dong, and Z. Lin, “Effects of Selenium Supplementation on Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis on Randomized Clinical Trials,” BMC Endocrine Disorders, vol. 23, p. 33, 2023.
[84] M. Jamilian, S. Mansury, and F. Bahmani, “The Effects of Probiotic and Selenium Co-Supplementation on Parameters of Mental Health, Hormonal Profiles, and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome,” Journal of Ovarian Research, vol. 11, p. 80, 2018.
[85] E. R., A. M. D., M. K., and P. T., “Oxidative Stress in Polycystic Ovary Syndrome,” Reproduction, vol. 164, no. 6, pp. F145–F154, 2022.
[86] Y. H. Ham, G. Pan, and H. W. Chan, “LC-MS/MS Quantitation of Formaldehyde–Glutathione Conjugates as Biomarkers of Formaldehyde Exposure and Exposure-Induced Antioxidants: A New Look at an Old Topic,” Chemical Research in Toxicology, vol. 35, no. 5, pp. 858–866, 2022.
[87] R. Dringen, “Metabolism and Functions of Glutathione in Brain,” Progress in Neurobiology, vol. 62, no. 6, pp. 649–671, 2000.
[88] C. Pimson, W. Chatuphonprasert, and K. Jarukamjorn, “Improvement of Antioxidant Balance in Diabetes Mellitus Type 1 Mice by Glutathione Supplement,” Pakistan Journal of Pharmaceutical Sciences, vol. 27, no. 6, pp. 1731–1737, 2014.
[89] R. C. Gomez and A. H. Mijares, “Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance,” Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 9, pp. 3505–3512, 2009.
[90] S. Stephenie, Y. P. Chang, A. Gnanasekaran, and N. M. Esa, “An Insight on Superoxide Dismutase (SOD) from Plants for Mammalian Health Enhancement,” Journal of Functional Foods, vol. 68, p. 103917, 2020.
[91] Y. Liang, Y. Han, and J. Dan, “A Highly Efficient and Stable Artificial Superoxide Dismutase Based on Functionalized Melanin Nanoparticles from Cuttlefish Ink for Food Preservation,” Food Research International, vol. 163, p. 112211, 2023.
[92] H. Younus, “Therapeutic Potentials of Superoxide Dismutase,” International Journal of Health Sciences, vol. 12, no. 3, pp. 88–98, 2018.
[93] K. H. Al-Gubory, P. A. Fowler, and J. Garrel, “The Roles of Cellular Reactive Oxygen Species, Oxidative Stress, and Antioxidants in Pregnancy Outcomes,” International Journal of Biochemistry & Cell Biology, vol. 42, no. 10, pp. 1634–1650, 2010.
[94] A. Agarwal, A. Aponte-Mellado, B. J. Premkumar, A. Shaman, and S. Gupta, “The Effects of Oxidative Stress on Female Reproduction: A Review,” Reproductive Biology and Endocrinology, vol. 10, no. 1, pp. 1–31, 2012.
[95] L. Poston, N. Igosheva, and H. D. Mistry, “Role of Oxidative Stress and Antioxidant Supplementation in Pregnancy Disorders,” American Journal of Clinical Nutrition, vol. 94, suppl. 6, pp. 1980S–1985S, 2011.
[96] M. Murri, M. Luque-Ramírez, M. Insenser, and M. Ojeda-Ojeda, “Circulating Markers of Oxidative Stress and Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis,” Human Reproduction Update, vol. 19, no. 3, pp. 268–288, 2013.
[97] K. Coulibaly, M. Thauvin, and A. Melenbacher, “A Di-Copper Peptidyl Complex Mimics the Activity of Catalase, a Key Antioxidant Metalloenzyme,” Inorganic Chemistry, vol. 60, no. 13, pp. 9309–9319, 2021.
[98] S. K. Pandey and R. M. Banik, “Selection and Optimization of Nutritional Constituents for Enhanced Production of Alkaline Phosphatase by Bacillus licheniformis MTCC 1483,” Journal of Agricultural Technology, vol. 8, no. 4, pp. 1317–1325, 2012.
[99] L. P. Atip, P. T. Natchai, and S. Charn, “Lipid Peroxidation and Antioxidant Enzyme Activities in Erythrocytes of Type 2 Diabetic Patients,” Journal of the Medical Association of Thailand, vol. 93, no. 6, pp. 187–190, 2010.
[100] D. D. Rio, A. J. Stewart, and A. Pellegrini, “A Review of Recent Studies on Malondialdehyde as Toxic Molecule and Biological Marker of Oxidative Stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 4, pp. 316–320, 2005.
[101] R. Buddi, B. Lin, and S. R. Atilano, “Evidence of Oxidative Stress in Human Corneal Diseases,” Journal of Histochemistry & Cytochemistry, vol. 50, no. 3, pp. 341–351, 2002.
[102] N. Gopal, A. Selvam, and A. R. Srinivasan, “Serum Gamma Glutamyl Transferase Levels in Obese South Indian Adults with Reference to Atherogenic Lipid Risk Factors and Lipid Peroxides,” International Journal of Medical and Health Sciences, vol. 1, no. 1, pp. 2–14, 2012.
[103] J. Cederberg, “Oxidative Stress; Antioxidative Defence and Outcome of Gestation in Experimental Diabetic Pregnancy,” Doctoral Dissertation, Acta Universitatis Upsaliensis, Uppsala University, 2001.
[104] H. Esterbauer, R. Schaur, and H. Zollner, “Chemistry and Biochemistry of 4-Hydroxynonenal, Malondialdehyde, and Related Aldehydes,” Free Radical Biology and Medicine, vol. 11, pp. 81–128, 1991.
[105] G. Willis, R. Hocking, M. Udiawar, and A. Rees, “Oxidative Stress and Nitric Oxide in Polycystic Ovary Syndrome,” Nitric Oxide, vol. 27, Suppl., p. S28, 2012.
[106] M. Murri, M. Luque-Ramírez, M. Insenser, and M. Ojeda-Ojeda, “Circulating Markers of Oxidative Stress and Polycystic Ovary Syndrome (PCOS): A Systematic Review and Meta-Analysis,” Human Reproduction Update, vol. 19, no. 3, pp. 268–288, 2013.
[107] J. Barp, A. S. D. R. Araújo, and T. R. G. Fernandes, “Myocardial Antioxidant and Oxidative Stress Changes Due to Sex Hormones,” Brazilian Journal of Medical and Biological Research, vol. 35, pp. 1075–1081, 2002.
[108] H. Lee, S. Lee, and J. Y. Baek, “Estrogenic Activity of Ethyl Gallate and Its Potential Use in Hormone Replacement Therapy,” Bioorganic & Medicinal Chemistry Letters, vol. 40, p. 127919, 2021.
[109] J. Vina, J. Gambini, and R. Lopez-Grueso, “Females Live Longer than Males: Role of Oxidative Stress,” Current Pharmaceutical Design, vol. 17, no. 36, pp. 3959–3965, 2011.
[110] M. Š. Goldštajn, K. Toljan, and F. Grgić, “Sex Hormone Binding Globulin (SHBG) as a Marker of Clinical Disorders,” Collegium Antropologicum, vol. 40, no. 3, pp. 211–218, 2016.
[111] H. N. Y. Siti, Y. Kamisah, and J. Kamsiah, “The Role of Oxidative Stress, Antioxidants and Vascular Inflammation in Cardiovascular Disease: A Review,” Vascular Pharmacology, vol. 71, pp. 40–56, 2015.
[112] N. Guo, Y. F. Li, and J. H. Ai, “Two Different Concentrations of Oxygen for Culturing Precompaction Stage Embryos on Human Embryo Development Competence: A Prospective Randomized Sibling-Oocyte Study,” International Journal of Clinical and Experimental Pathology, vol. 7, pp. 6191–6198, 2014.
[113] A. Al-Mulla, A. B. E. Fazari, M. Elkhouly, and N. Moghaddam, “Role of Antioxidants in Female Fertility,” Open Journal of Obstetrics and Gynecology, vol. 8, pp. 85–91, 2018.
[114] B. Kovačič, “Culture Systems: Low-Oxygen Culture,” in Methods in Molecular Biology, vol. 912, Clifton, NJ: Humana Press, 2012, pp. 249–272.
[115] M. S. Hamza, M. S. Raheem, and S. J. Abdurrahman, “Correlation Between Levels of Serum Antioxidants and Numerous Hormones in Primary Infertility of Women,” International Journal of Reproductive BioMedicine, vol. 18, no. 10, pp. 1–8, 2020.
[116] J. C. M. Riley and H. R. Behrman, “Oxygen Radicals and Reactive Oxygen Species in Reproduction,” Proceedings of the Society for Experimental Biology and Medicine, vol. 198, no. 3, pp. 781–791, 1991.
[117] H. R. Behrman, S. L. Kodaman, S. Preston, and S. Gao, “Oxidative Stress and the Ovary,” Journal of the Society for Gynecologic Investigation, vol. 8, no. 1, pp. S40–S42, 2001.